YHB Principal Adrian Taylor discusses law firm profitability, tax planning, partner succession, cash flow management and the financial impact of AI.

Sacituzumab govitecan extends survival in advanced endometrial cancer post chemotherapy and immunotherapy, per phase 3 data.

Sky Metals Limited (ASX:SKY) has released its Quarterly Activities Report for the September 2026 quarter, disclosing the ...

Victory Metals Limited (ASX:VTM) has released its quarterly activities report for the period ending 30 September 2026, ...

Emerita Resources has completed a Prefeasibility Study for its Iberian Belt West Project in Spain, outlining a 21-year mine ...

Santa Rosa paint booth manufacturer Platinum Finishing Systems (PFS) exhibited at FABTECH 2026 in Las Vegas, Booth ...

Divarasib leads to significantly longer progression-free and overall survival than control treatment for patients with ...

Trastuzumab rezetecan significantly improves progression-free survival in HER2-low advanced breast cancer, regardless of ...

Single-agent immunotherapy as first-line treatment led to a huge improvement in progression-free survival (PFS) in inoperable recurrent/advanced mismatch repair-deficient (dMMR) endometrial cancer, a ...

Provident Financial (PFS) delivered earnings and revenue surprises of -11.67% and +0.13%, respectively, for the quarter ended ...

Regional bank Provident Financial Services (NYSE:PFS) met Wall Street’s revenue expectations in Q3 2026, with revenue up 7.6% ...

HyProMag is developing advanced rare earth magnet recycling and manufacturing operations to establish a secure domestic U.S.